Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	endocytic vesicle	CYBB ABCA1 SPARC MYO6 INPP5B HLA-DRA SYT9 NCF2 ITGB5 FFAR4 NOD1 SYK AMN MPEG1 EGF LRP1	4.50e-06	384	225	16	GO:0030139
GeneOntologyCellularComponent	sarcolemma	RYR2 RYR3 DST KCNJ12 TRIM72 COL6A2 COL6A3 ANK3 KCNJ18	2.25e-04	190	225	9	GO:0042383
GeneOntologyCellularComponent	phagocytic vesicle	CYBB ABCA1 INPP5B NCF2 ITGB5 NOD1 SYK MPEG1	3.08e-04	157	225	8	GO:0045335
GeneOntologyCellularComponent	ribbon synapse	MYO6 NPHP4 DIAPH3 ATP2B1	3.71e-04	32	225	4	GO:0097470
Domain	VWA	ITGB5 PARP4 MDN1 HMCN2 COL6A2 COL6A3 COL6A6 VWA7	6.82e-06	84	221	8	SM00327
Domain	VWF_A	ITGB5 PARP4 MDN1 HMCN2 COL6A2 COL6A3 COL6A6 VWA7	2.30e-05	99	221	8	IPR002035
Domain	VWFA	ITGB5 PARP4 MDN1 HMCN2 COL6A2 COL6A3 COL6A6	5.29e-05	82	221	7	PS50234
Domain	K_chnl_inward-rec_Kir2.2	KCNJ12 KCNJ18	1.39e-04	2	221	2	IPR003272
Domain	Fucokinase	FPGT FCSK	1.39e-04	2	221	2	IPR012887
Domain	Fucokinase	FPGT FCSK	1.39e-04	2	221	2	PF07959
Domain	-	ITGB5 PARP4 MDN1 COL6A2 COL6A3 COL6A6	2.43e-04	74	221	6	3.40.50.410
Domain	BRCT_dom	TERF2IP PARP4 MDC1 SMARCC2	3.13e-04	28	221	4	IPR001357
Domain	RyR	RYR2 RYR3	4.15e-04	3	221	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	4.15e-04	3	221	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	4.15e-04	3	221	2	IPR013333
Domain	K_chnl_inward-rec_Kir_N	KCNJ12 KCNJ18	4.15e-04	3	221	2	IPR013673
Domain	Ryanodine_rcpt	RYR2 RYR3	4.15e-04	3	221	2	IPR003032
Domain	IRK_N	KCNJ12 KCNJ18	4.15e-04	3	221	2	PF08466
Domain	Ryanrecept_TM4-6	RYR2 RYR3	4.15e-04	3	221	2	IPR009460
Pathway	REACTOME_ECM_PROTEOGLYCANS	SPARC ITGB5 COL4A5 COL6A2 COL6A3 COL6A6 LAMA5	3.84e-05	76	172	7	M27219
Pathway	PID_RAC1_PATHWAY	CYBB NCF2 IQGAP3 ACTR2 NOX1 CDH1	4.81e-05	54	172	6	M278
Pathway	REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	MMP1 COL4A5 COL6A2 COL6A3 COL6A6 LAMA5 CAPN11 TLL1 CDH1	5.42e-05	140	172	9	M587
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A5 COL6A2 COL6A3 COL6A6 GRB7 SOS1	6.55e-05	57	172	6	MM14713
Pathway	BIOCARTA_IL2RB_PATHWAY	JAK3 SYK E2F1 IL2RB SOS1	7.08e-05	36	172	5	MM1418
Pathway	REACTOME_SIGNALING_BY_PDGF	COL4A5 COL6A2 COL6A3 COL6A6 GRB7 SOS1	7.24e-05	58	172	6	M2049
Pathway	REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	ITGB5 FGB COL4A5 COL6A2 COL6A3 COL6A6 CDH1	7.90e-05	85	172	7	M16441
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	SPARC ITGB5 DST FGB MMP1 COL4A5 COL6A2 COL6A3 COL6A6 LAMA5 CAPN11 TLL1 CDH1	8.00e-05	300	172	13	M610
Pathway	BIOCARTA_IL2RB_PATHWAY	JAK3 SYK E2F1 IL2RB SOS1	8.11e-05	37	172	5	M8615
Pathway	REACTOME_NCAM1_INTERACTIONS	COL4A5 COL6A2 COL6A3 COL6A6	8.90e-05	20	172	4	MM15061
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL4A5 COL6A2 COL6A3 COL6A6 SOS1	9.24e-05	38	172	5	MM14969
Pathway	REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES	CYBB NCF2 ITGB5	9.56e-05	8	172	3	M26926
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	DST COL4A5 COL6A2 COL6A3 COL6A6 TLL1	9.63e-05	61	172	6	M27103
Pathway	BIOCARTA_IL2_PATHWAY	JAK3 SYK IL2RB SOS1	1.32e-04	22	172	4	M7747
Pathway	WP_IL2_SIGNALING	MAPT JAK3 SYK IL2RB SOS1	1.51e-04	42	172	5	M39536
Pathway	BIOCARTA_IL2_PATHWAY	JAK3 SYK IL2RB SOS1	1.58e-04	23	172	4	MM1411
Pathway	REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING	JAK3 SYK IL2RB IL9R SOS1	1.89e-04	44	172	5	M1012
Pathway	PID_SYNDECAN_1_PATHWAY	MMP1 COL4A5 COL6A2 COL6A3 LAMA5	2.33e-04	46	172	5	M198
Pathway	WP_NONSMALL_CELL_LUNG_CANCER	BID JAK3 FHIT E2F1 EGF SOS1	2.43e-04	72	172	6	M39738
Pathway	WP_ALZHEIMERS_DISEASE	MAPT RYR3 BID GRIN2D CHP2 LRP1	2.82e-04	74	172	6	MM15962
Pathway	REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES	COL4A5 COL6A2 COL6A3 COL6A6 TLL1	3.47e-04	50	172	5	MM14796
Pathway	REACTOME_INTERLEUKIN_2_SIGNALING	JAK3 SYK IL2RB	3.62e-04	12	172	3	M27893
Pathway	REACTOME_COLLAGEN_DEGRADATION	MMP1 COL4A5 COL6A2 COL6A3 COL6A6	4.56e-04	53	172	5	MM14566
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TANC2 SPHK2 MGAT4B NDOR1 PCNX3 FBXL12 PARVB NCLN NPHP4 ITGB5 GGT7 JAK3 ZGPAT TMEM129 DST MDN1 SLC35A2 DOCK6 IQGAP3 NPC1 COL4A5 ARSJ ITPRIPL2 POLE GRK5 NLRX1 LAMA5 GRIN2D SBNO2 MST1R MROH1 NINL SLC45A1	3.56e-13	1105	227	33	35748872
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MGAT4B GGNBP2 GON4L NCLN PARP4 DST UGDH CHPF2 TMEM223 IQGAP3 DHX16 COL6A2 POGK POLE GRB7 PAPSS2 SBNO2 TLL1 SORL1	6.64e-08	650	227	19	38777146
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	NCLN ITGB5 LRIG2 CHPF2 NPC1 LAMA5 MST1R TENM4 LRP1 SORL1	1.40e-07	164	227	10	32409323
Pubmed	Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin.	MKI67 ANK3 CDH1	1.09e-06	4	227	3	24821222
Pubmed	Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.	JAK3 IL2RB IL9R	1.09e-06	4	227	3	18829468
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	DNAJB12 MBTPS1 MGAT4B QPCTL NCLN ITGB5 SLC39A13 GGT7 LRIG2 SLC35A2 CHPF2 NPC1 COL4A5 ITPRIPL2 LAMA5 RANBP6 ST6GAL1 TMEM43 MST1R NETO2 TLL1 LRP1 ATP2B1 SORL1	1.33e-06	1201	227	24	35696571
Pubmed	Functional proteomics mapping of a human signaling pathway.	SPINT1 MYO6 PSMC2 TRIM29 TRIP12 RYR2 MTMR11 DST NIT1 DIAPH3 KDM6A ANK3 LAMA5 RANBP6 LRP1 SNRPA	2.02e-06	591	227	16	15231748
Pubmed	Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins.	CYBB NCF2 NOX1	2.72e-06	5	227	3	15256399
Pubmed	The expanded collagen VI family: new chains and new questions.	COL6A2 COL6A3 COL6A6	2.72e-06	5	227	3	23869615
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	ACACB GON4L ADAR TRIP12 DST MDN1 FAT3 SNX25 MDC1 SMARCC2	3.60e-06	234	227	10	36243803
Pubmed	Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development.	SPINT1 MKI67 CDH1	5.41e-06	6	227	3	16983341
Pubmed	Asynchrony of Apical Polarization, Luminogenesis, and Functional Differentiation in the Developing Thyroid Gland.	MKI67 TG CDH1	5.41e-06	6	227	3	34975747
Pubmed	Thyroid follicle development requires Smad1/5- and endothelial cell-dependent basement membrane assembly.	COL4A5 LAMA5 TG PARD3 CDH1	6.19e-06	40	227	5	27068110
Pubmed	Novel human homologues of p47phox and p67phox participate in activation of superoxide-producing NADPH oxidases.	CYBB NCF2 NOX1	9.42e-06	7	227	3	12716910
Pubmed	Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI).	COL6A2 COL6A3 COL6A6	9.42e-06	7	227	3	18400749
Pubmed	Three novel collagen VI chains with high homology to the alpha3 chain.	COL6A2 COL6A3 COL6A6	9.42e-06	7	227	3	18276594
Pubmed	Critical role of the BAF chromatin remodeling complex during murine neural crest development.	MKI67 E2F1 SMARCC2	1.50e-05	8	227	3	33750945
Pubmed	Fras1 deficiency results in cryptophthalmos, renal agenesis and blebbed phenotype in mice.	COL6A2 COL6A3 LAMA5	1.50e-05	8	227	3	12766770
Pubmed	Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS.	MAPT KCNJ12 KCNJ18	1.50e-05	8	227	3	27930290
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DNAJB12 MBTPS1 IMPA2 MYO6 MAPT PARVB ADGRV1 ITGB5 NDUFS3 TERF2IP SYNJ2 CLK2 DOCK6 KDM6A COL4A5 ANK3 C11orf54 SBNO2 ASMTL TLL1 LRP1 CSMD1 PARD3 ATP2B1 ICA1L	1.63e-05	1489	227	25	28611215
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	SPARC HMCN2 FGB COL4A5 COL6A2 COL6A3 COL6A6 LAMA5	2.12e-05	175	227	8	28071719
Pubmed	Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition.	MKI67 PARD3 CDH1 SORL1	2.76e-05	27	227	4	27178982
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GGNBP2 ACACB CHD4 TRIP12 PSMA8 RYR2 DST MDN1 GSPT2 DIAPH3 DCAF13 PCDHGC5 GRK5 TMEM43 ACTR2 CAPN11 TBC1D31 FAM50A ETHE1 SNX25 SMARCC2 CFAP74 CDH1 ATP2B1	2.79e-05	1442	227	24	35575683
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	DNAJB12 QPCTL NAP1L4 ADAR GGT7 PASK MKI67 IQGAP3 TMEM43 SNRPA SORL1	3.07e-05	364	227	11	24778252
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	DNAJB12 ACADL CHD4 NCLN ADAR ITGB5 PSMA8 NDUFS3 SLC39A13 RAB3GAP2 UGDH RAD51C MPST COL6A2 LAMA5 ACAD10 TMEM43 ACTR2 FRRS1 ETHE1 LRP1 SMARCC2 ATP2B1 TPBG	3.08e-05	1451	227	24	30550785
Pubmed	Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.	JAK3 SYK IL2RB	3.18e-05	10	227	3	10825200
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	MAPT MKI67 ANK3	3.18e-05	10	227	3	22159418
Pubmed	Embryonic expression of murine 5T4 oncofoetal antigen is associated with morphogenetic events at implantation and in developing epithelia.	MKI67 CDH1 TPBG	3.18e-05	10	227	3	15977177
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	TANC2 ABCF3 PSMC2 CHD4 PARVB TRIP12 BID PARP4 MDN1 DIAPH3 POLE ACTR2 SMARCC2 SNRPA	3.28e-05	582	227	14	20467437
Pubmed	Construction of a multi-functional cDNA library specific for mouse pancreatic islets and its application to microarray.	TANC2 MBTPS1 PLK2 ABCA1 NPHP4 ADAR FARSA OSGIN2 ACTR2 EGF CDH1	3.65e-05	371	227	11	15747579
Pubmed	Nitrilase and Fhit homologs are encoded as fusion proteins in Drosophila melanogaster and Caenorhabditis elegans.	NIT1 FHIT	4.24e-05	2	227	2	9671749
Pubmed	Dynamic interactions between E-cadherin and Ankyrin-G mediate epithelial cell polarity maintenance.	ANK3 CDH1	4.24e-05	2	227	2	37891324
Pubmed	Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study.	GCK GCKR	4.24e-05	2	227	2	35276241
Pubmed	Tau deletion exacerbates the phenotype of Niemann-Pick type C mice and implicates autophagy in pathogenesis.	MAPT NPC1	4.24e-05	2	227	2	19074461
Pubmed	The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.	CYBB NOX1	4.24e-05	2	227	2	16877542
Pubmed	Redox modifier genes in amyotrophic lateral sclerosis in mice.	CYBB NOX1	4.24e-05	2	227	2	17853944
Pubmed	Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis.	CYBB NOX1	4.24e-05	2	227	2	27212019
Pubmed	Increased Expression of the ABCA1 and ABCA3 Transporter Genes is Associated with Cisplatin Resistance in Breast Cancer Cells.	ABCA1 ABCA3	4.24e-05	2	227	2	38019257
Pubmed	E3 Ubiquitin Ligase APC/CCdh1 Regulation of Phenylalanine Hydroxylase Stability and Function.	PAH CDH1	4.24e-05	2	227	2	33260674
Pubmed	Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis.	CYBB NOX1	4.24e-05	2	227	2	26988594
Pubmed	VEO-IBD NOX1 variant highlights a structural region essential for NOX/DUOX catalytic activity.	CYBB NOX1	4.24e-05	2	227	2	37820403
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	4.24e-05	2	227	2	8898078
Pubmed	The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.	CYBB NOX1	4.24e-05	2	227	2	24494191
Pubmed	The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.	GCK GCKR	4.24e-05	2	227	2	18008060
Pubmed	Time-course changes in immunoreactivities of glucokinase and glucokinase regulatory protein in the gerbil hippocampus following transient cerebral ischemia.	GCK GCKR	4.24e-05	2	227	2	24146201
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	4.24e-05	2	227	2	14550562
Pubmed	Epigenetic regulation of E-cadherin expression by the histone demethylase UTX in colon cancer cells.	KDM6A CDH1	4.24e-05	2	227	2	26819089
Pubmed	Neural crest E-cadherin loss drives cleft lip/palate by epigenetic modulation via pro-inflammatory gene-environment interaction.	E2F1 CDH1	4.24e-05	2	227	2	37225711
Pubmed	Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations.	GCK GCKR	4.24e-05	2	227	2	17082186
Pubmed	Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.	GCK GCKR	4.24e-05	2	227	2	22038520
Pubmed	CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.	CHD4 CDH1	4.24e-05	2	227	2	29305962
Pubmed	Netrin-1 abrogates ischemia/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS.	CYBB NOX1	4.24e-05	2	227	2	25066694
Pubmed	The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.	KDM6A CDH1	4.24e-05	2	227	2	29351209
Pubmed	Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.	MAPT SYK	4.24e-05	2	227	2	28919467
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	4.24e-05	2	227	2	21531043
Pubmed	Amino acid conservation in animal glucokinases. Identification of residues implicated in the interaction with the regulatory protein.	GCK GCKR	4.24e-05	2	227	2	8626423
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	4.24e-05	2	227	2	16678258
Pubmed	PAS Kinase deficiency alters the glucokinase function and hepatic metabolism.	GCK PASK	4.24e-05	2	227	2	30038292
Pubmed	NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice.	CYBB NOX1	4.24e-05	2	227	2	19661248
Pubmed	Sialylation by β-galactoside α-2,6-sialyltransferase and N-glycans regulate cell adhesion and invasion in human anaplastic large cell lymphoma.	ST6GAL1 LGALS8	4.24e-05	2	227	2	25573487
Pubmed	Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides.	CYBB RYR2	4.24e-05	2	227	2	24104877
Pubmed	The Rosetta Stone Hypothesis-Based Interaction of the Tumor Suppressor Proteins Nit1 and Fhit.	NIT1 FHIT	4.24e-05	2	227	2	36766695
Pubmed	Endothelial NADPH oxidases: which NOX to target in vascular disease?	CYBB NOX1	4.24e-05	2	227	2	25066192
Pubmed	Loss of E-Cadherin Expression Correlates With Ki-67 in Head and Neck Squamous Cell Carcinoma.	MKI67 CDH1	4.24e-05	2	227	2	35478157
Pubmed	Differences in regulatory properties between human and rat glucokinase regulatory protein.	GCK GCKR	4.24e-05	2	227	2	14627435
Pubmed	NADPH Oxidases Are Essential for Macrophage Differentiation.	CYBB NOX1	4.24e-05	2	227	2	27489105
Pubmed	The juxtamembrane domain of the E-cadherin cytoplasmic tail contributes to its interaction with Myosin VI.	MYO6 CDH1	4.24e-05	2	227	2	23007415
Pubmed	GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).	GCK GCKR	4.24e-05	2	227	2	36243233
Pubmed	The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.	GCK GCKR	4.24e-05	2	227	2	18556336
Pubmed	The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.	GCK GCKR	4.24e-05	2	227	2	19643913
Pubmed	Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.	MKI67 CDH1	4.24e-05	2	227	2	22126395
Pubmed	Epistasis between intracellular cholesterol trafficking-related genes (NPC1 and ABCA1) and Alzheimer's disease risk.	ABCA1 NPC1	4.24e-05	2	227	2	20571217
Pubmed	ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity.	ABCA1 NPC1	4.24e-05	2	227	2	12215451
Pubmed	Tumor biomarkers in cervical cancer: focus on Ki-67 proliferation factor and E-cadherin expression.	MKI67 CDH1	4.24e-05	2	227	2	19690767
Pubmed	Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.	CYBB NCF2	4.24e-05	2	227	2	22562447
Pubmed	Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.	MAPT SYK	4.24e-05	2	227	2	31324720
Pubmed	Lysine-specific Demethylase 6A Upregulates Cadherin-1 and Accelerates Gastric Cancer Growth.	KDM6A CDH1	4.24e-05	2	227	2	36941815
Pubmed	Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.	GCK GCKR	4.24e-05	2	227	2	17186219
Pubmed	Adverse cognitive effects of high-fat diet in a murine model of sleep apnea are mediated by NADPH oxidase activity.	CYBB NOX1	4.24e-05	2	227	2	23064009
Pubmed	NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice.	CYBB NOX1	4.24e-05	2	227	2	24379900
Pubmed	A novel conserved targeting motif found in ABCA transporters mediates trafficking to early post-Golgi compartments.	ABCA1 ABCA3	4.24e-05	2	227	2	21586796
Pubmed	Structural basis for regulation of human glucokinase by glucokinase regulatory protein.	GCK GCKR	4.24e-05	2	227	2	23957911
Pubmed	SYK kinase mediates brown fat differentiation and activation.	NDOR1 SYK	4.24e-05	2	227	2	29235464
Pubmed	Treatment of type 2 diabetes by adenoviral-mediated overexpression of the glucokinase regulatory protein.	GCK GCKR	4.24e-05	2	227	2	11473043
Pubmed	Histone H3 lysine 4 methylation signature associated with human undernutrition.	NDOR1 LRP1	4.24e-05	2	227	2	30420518
Pubmed	Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases.	CYBB NOX1	4.24e-05	2	227	2	22412195
Pubmed	Analysis of the co-operative interaction between the allosterically regulated proteins GK and GKRP using tryptophan fluorescence.	GCK GCKR	4.24e-05	2	227	2	24568320
Pubmed	Galectin-8-mediated selective autophagy protects against seeded tau aggregation.	MAPT LGALS8	4.24e-05	2	227	2	29282296
Pubmed	Characterization of glucokinase regulatory protein-deficient mice.	GCK GCKR	4.24e-05	2	227	2	10713097
Pubmed	Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.	GCK GCKR	4.24e-05	2	227	2	19073768
Pubmed	Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse.	KCNJ12 KCNJ18	4.24e-05	2	227	2	15705530
Pubmed	GIPC3 couples to MYO6 and PDZ domain proteins, and shapes the hair cell apical region.	MYO6 GIPC3	4.24e-05	2	227	2	37096733
Pubmed	Nit1 and Fhit tumor suppressor activities are additive.	NIT1 FHIT	4.24e-05	2	227	2	19479888
Pubmed	A Cys-Gly-Cys triad in the dehydrogenase region of Nox2 plays a key role in the interaction with p67phox.	CYBB NCF2	4.24e-05	2	227	2	26160850
Pubmed	Activation of the flavoprotein domain of gp91phox upon interaction with N-terminal p67phox (1-210) and the Rac complex.	CYBB NCF2	4.24e-05	2	227	2	15260500
Pubmed	Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue.	ABCA1 ABCA3	4.24e-05	2	227	2	19902402
Pubmed	Pim-1L Protects Cell Surface-Resident ABCA1 From Lysosomal Degradation in Hepatocytes and Thereby Regulates Plasma High-Density Lipoprotein Level.	ABCA1 PIM1	4.24e-05	2	227	2	27765770
Pubmed	Activation of NADPH oxidases leads to DNA damage in esophageal cells.	CYBB NOX1	4.24e-05	2	227	2	28855537
Pubmed	Molecular basis for the role of glucokinase regulatory protein as the allosteric switch for glucokinase.	GCK GCKR	4.24e-05	2	227	2	23733961
Pubmed	Organization of the human glucokinase regulator gene GCKR.	GCK GCKR	4.24e-05	2	227	2	9570959
Interaction	TOP3B interactions	TANC2 SPHK2 MGAT4B NDOR1 PCNX3 MYO6 FBXL12 PARVB NCLN NPHP4 ITGB5 GGT7 JAK3 ZGPAT TMEM129 DST MDN1 SLC35A2 DOCK6 IQGAP3 NPC1 COL4A5 ARSJ ITPRIPL2 POLE GRK5 NLRX1 LAMA5 GRIN2D ACTR2 SBNO2 MST1R MROH1 MDC1 NINL SLC45A1 SNRPA	1.69e-06	1470	221	37	int:TOP3B
Interaction	DKKL1 interactions	MBTPS1 MGAT4B ADGRV1 MDN1 UGDH RAD51C COL6A2 POLE FAT3	3.74e-06	111	221	9	int:DKKL1
Interaction	GGH interactions	MBTPS1 MYO6 ADGRV1 TRIP12 LRIG2 UGDH MKI67 CHPF2 FHIT COL6A2 LAMA5 TMEM43	1.64e-05	243	221	12	int:GGH
GeneFamily	Phosphoinositide phosphatases	IMPA2 INPP5B SYNJ2 MTMR2	1.08e-04	32	141	4	1079
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	1.80e-04	3	141	2	287
GeneFamily	Collagens	COL4A5 COL6A2 COL6A3 COL6A6	4.49e-04	46	141	4	490
Coexpression	GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN	DNAJB12 MBTPS1 BID NOD1 PPME1 NEURL1B GPR4 RANBP6 GSAP SNRPA	9.29e-06	200	224	10	M8494
Coexpression	GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	CYBB IL11RA SPINT1 NCF2 TRIM29 FFAR4 BCAR3 COL6A3 GRK5 CDH1	9.29e-06	200	224	10	M6212
CoexpressionAtlas	Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3	CYBB MGAT4B SPINT1 MYO6 NCF2 TRIM29 ITGB5 FFAR4 DST BCAR3 ITPRIPL2 GRK5 MPEG1 GSAP LRP1 CDH1	1.18e-05	425	223	16	GSM538282_500
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ABCA1 MYO6 ADGRV1 SLC9C1 DST ANK3 LAMA5 PAPSS2 SNX25 PARD3 CDH1	1.29e-09	170	227	11	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TANC2 MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 GSAP	2.65e-09	182	227	11	be48ce85991bceeff938ba080e6bf9cc62176b05
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TANC2 TRH SPINT1 TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 LRP1 CDH1	2.98e-09	184	227	11	bd5e8fc453a6393b8778734a2c3c2f1281769bcd
ToppCell	droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TANC2 TRH SPINT1 TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 LRP1 CDH1	2.98e-09	184	227	11	15ea746c77785120f69f9ab370fb7eb9b70692f8
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TANC2 MGAT4B TRH TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 GSAP LRP1	2.98e-09	184	227	11	8fa30789c9d583188667cf375d2218e392dd40bc
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TANC2 MGAT4B ABCA1 TRH TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 GSAP	3.15e-09	185	227	11	4bee178ede12f56ba5f5bec44a03dc2a62c50137
ToppCell	droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TANC2 TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 GSAP	3.34e-08	181	227	10	8fcdab61fad2efd324d2b27c58f5a594f1dc15de
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH TRIM29 FFAR4 DST BCAR3 NEURL1B NPC1 ITPRIPL2 MPEG1 E2F1	4.10e-08	185	227	10	775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRH TRIM29 FFAR4 DST BCAR3 NEURL1B NPC1 ITPRIPL2 MPEG1 E2F1	4.10e-08	185	227	10	afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b
ToppCell	droplet-Lung-nan-21m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 CDH1	4.32e-08	186	227	10	8f77e552e613b6e124443c7f6ef5c1316a5ff8db
ToppCell	droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 CDH1	4.32e-08	186	227	10	f1aa0c58336d23bcbe52a59e7af954d20085bdb6
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCA3 IMPA2 ADGRV1 COL4A5 ARSJ ANK3 GSAP TENM4 CDH1	4.32e-08	186	227	10	e83718fabb057100835d3357df407f283d23fe16
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 GSAP	5.02e-08	189	227	10	b2542b6fcf7bc10d29158d42b03182a939ff135a
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	CYBB IL11RA ACADL DST BCAR3 NPC1 ITPRIPL2 MPEG1 GSAP LRP1	5.54e-08	191	227	10	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TANC2 ABCA3 ACADL ADGRV1 NPC1 GPLD1 ANK3 SNX25 PARD3 CDH1	6.42e-08	194	227	10	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ACADL MYO6 ADGRV1 SLC9C1 FHIT ANK3 SNX25 PARD3 CDH1	8.15e-08	199	227	10	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-B\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CYBB MGAT4B NCF2 TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 GSAP	1.41e-07	160	227	9	694bf1f1952bd8ab444819f533da24fa2b73f701
ToppCell	Control\|World / group, cell type (main and fine annotations)	ABCA3 ACADL MYO6 ADGRV1 SLC9C1 ANK3 SNX25 PARD3 CDH1	2.13e-07	168	227	9	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UGDH MPST AMN C11orf54 PAPSS2 ETHE1 LRP1 B4GALNT2 ATP2B1	2.36e-07	170	227	9	75b0486620cab838d3feb1c3aa965b487a906618
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TRH SPINT1 NCF2 TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1	3.32e-07	177	227	9	71919b5c9bfa87fdd2cd44dfa057b66ea081be5d
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCA3 ADGRV1 COL4A5 ARSJ ANK3 GSAP TENM4 CDH1	3.65e-07	179	227	9	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	CD8+_Memory_T_cell-RSV-2\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	IL11RA IMPA2 PARVB FPGT DENND6B MKI67 DIAPH3 NETO2 SNRPA	4.19e-07	182	227	9	f5f17a80552f0ad05ed1a2529a04ee55deb1e130
ToppCell	droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 TRH SPINT1 TRIM29 FFAR4 BCAR3 NPC1 ITPRIPL2 MPEG1	4.39e-07	183	227	9	ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f
ToppCell	facs-Lung-24m-Hematologic-myeloid\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB SPINT1 SNX20 NCF2 FFAR4 PIM1 SYK TNFAIP8L2 MPEG1	4.60e-07	184	227	9	c451acfcd8fe28c1f4b1ea334b1129fa84a15c42
ToppCell	droplet-Lung-nan-3m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 TRH SPINT1 TRIM29 FFAR4 BCAR3 NPC1 ITPRIPL2 MPEG1	4.60e-07	184	227	9	3261d767d5e3d9e9fbac22ad73ca14e44beed89c
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYBB ADGRV1 CSMD3 RYR2 OGFR MPEG1 TENM4 LRP1 CSMD1	5.03e-07	186	227	9	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPINT1 CYP2W1 ALOX15B AMN NOX1 ETHE1 CHP2 CDH1 SORL1	5.27e-07	187	227	9	1909b65ba23d598e396f77eecae562bb59bf5d5d
ToppCell	droplet-Lung-nan-18m-Myeloid-alveolar_macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 GSAP	5.27e-07	187	227	9	f0c6e53035b00772377c4d5f761b4d11026b911a
ToppCell	droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1 GSAP	5.27e-07	187	227	9	f20e7a1751694390f535ffb27b97e887220f8695
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SYT9 SYK BCAR3 COL4A5 ARSJ ANK3 PAPSS2 B4GALNT2	5.27e-07	187	227	9	e3095455d2f255854f339f6b05fa87852af0700f
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCA3 ADGRV1 COL4A5 ARSJ ANK3 GSAP TENM4 CDH1	5.51e-07	188	227	9	4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ABCA3 ACADL MYO6 ADGRV1 SLC9C1 ANK3 SNX25 PARD3 CDH1	5.51e-07	188	227	9	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYT9 SYK BCAR3 COL4A5 ANK3 ST6GAL1 PAPSS2 B4GALNT2 CDH1	5.76e-07	189	227	9	3a295c215b5c18e7c673f92b7af5be523421682c
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Epithelial-mature_enterocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPINT1 CYP2W1 ALOX15B AMN NOX1 ETHE1 CHP2 CDH1 SORL1	5.76e-07	189	227	9	8478f433495dabe813146a1f6b00098db8ce775a
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAT4B TRH TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1 GSAP CDH1	5.76e-07	189	227	9	287e59104687fe1665232c52993889f0f2c97f17
ToppCell	droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 GSAP CDH1	5.76e-07	189	227	9	f7e9b6e6a4de297b660a5b6c9a62f860c147185e
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO6 SYT9 SLC9C1 SYK ANK3 ST6GAL1 PAPSS2 B4GALNT2 CDH1	5.76e-07	189	227	9	532aaf02b364c5c4f58a2021c7c21d86df3875c9
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB MGAT4B TRH TRIM29 FFAR4 DST BCAR3 ITPRIPL2 MPEG1	6.02e-07	190	227	9	da58227565ad6a690828dd8554dd3670222f8582
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 ABCA3 ACADL MYO6 ADGRV1 ALOX15B ANK3 SNX25 PARD3	6.86e-07	193	227	9	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TANC2 ABCA3 ACADL MYO6 ADGRV1 ALOX15B ANK3 SNX25 PARD3	6.86e-07	193	227	9	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ABCA3 ACADL MYO6 ADGRV1 SLC9C1 ANK3 SNX25 PARD3 CDH1	7.48e-07	195	227	9	9406866f99555198a9be311fbd65751b70f35446
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYBB SPARC HLA-DRA NCF2 FFAR4 DST SYK LRP1 SORL1	8.14e-07	197	227	9	33f2fe101ae5744eea3915add37e60aa398bb97f
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CYBB SPARC HLA-DRA NCF2 FFAR4 DST SYK LRP1 SORL1	8.14e-07	197	227	9	9262785807faeb32417fad7ef202405053e453e2
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CYBB SPARC HLA-DRA NCF2 FFAR4 DST SYK LRP1 SORL1	8.14e-07	197	227	9	d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CYBB SPARC HLA-DRA NCF2 FFAR4 DST SYK LRP1 SORL1	8.14e-07	197	227	9	5e9a3932ae5147a3d73dc70f1545926a692930ed
ToppCell	Severe_COVID-19-Myeloid-TRAM2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CYBB SPARC HLA-DRA NCF2 FFAR4 DST SYK LRP1 SORL1	8.14e-07	197	227	9	8a126cfe1529f3d75a806aa492743314a8a43ef9
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IMPA2 HLA-DRA NCF2 PARVB MTMR11 DST SYK MPEG1 LRP1	8.49e-07	198	227	9	c1fe38594bd6292fcc60bdbb563376b454731d00
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL11RA SPARC ITGB5 UGDH COL4A5 COL6A2 COL6A3 LRP1 LRRC17	8.49e-07	198	227	9	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IMPA2 HLA-DRA NCF2 PARVB MTMR11 DST SYK MPEG1 LRP1	8.49e-07	198	227	9	bfc15de70a7577a2860b53e1e6826a7b5ad23040
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA3 ACADL MYO6 ADGRV1 FHIT ANK3 SNX25 PARD3 CDH1	8.85e-07	199	227	9	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TANC2 ABCA3 ACADL MYO6 ADGRV1 ANK3 SNX25 PARD3 CDH1	8.85e-07	199	227	9	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TANC2 ABCA3 ADGRV1 COL4A5 ARSJ ANK3 GRB7 GSAP CDH1	9.23e-07	200	227	9	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Biopsy_IPF-Epithelial-Basal\|Biopsy_IPF / Sample group, Lineage and Cell type	SPINT1 TRIM29 DST MMP1 COL4A5 ARSJ LAMA5 WNT10A TPBG	9.23e-07	200	227	9	5cea84581201cee7ba8141b96e65864f4fd67113
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IL11RA TRH SPINT1 CHRNA3 MKI67 GRB7 MST1R TPBG	1.00e-06	149	227	8	fe9dff31a30dabd212d53d1295f9f13ff32cb217
ToppCell	facs-Lung-Endomucin-24m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB SNX20 NCF2 SYK TNFAIP8L2 MPEG1 ETHE1 LRP1	1.22e-06	153	227	8	9c3220604b7fa4d91577b6c46960960f49644ca1
ToppCell	facs-Lung-Endomucin-24m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB SNX20 NCF2 SYK TNFAIP8L2 MPEG1 ETHE1 LRP1	1.22e-06	153	227	8	ba624782693b0daa642e50881dbf5f0663fea82d
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB SPARC TRH MKI67 TNFAIP8L2 MPEG1 LAMA5 KCNK12	1.35e-06	155	227	8	0e24e767a3895d31d34cabeaca0354aadae34e44
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB SPARC TRH MKI67 TNFAIP8L2 MPEG1 LAMA5 KCNK12	1.35e-06	155	227	8	f3489a548a2c0cc2d9117ff85865c6089ea0835d
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TANC2 ABCA1 TRH ITGB5 DST SNX25 CHP2 LRP1	1.71e-06	160	227	8	0544bc465af208da448858d6e174ff56f2e08a46
ToppCell	NS-control-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	IMPA2 PARVB DOCK6 PDE11A FAT3 GRK5 B4GALNT2 PNMA6A	2.26e-06	166	227	8	6d9fb239f69ba519844f593c00d515e1aac4ff50
ToppCell	facs-Large_Intestine-Proximal\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SNX20 UGDH MPST AMN C11orf54 LRP1 B4GALNT2 ATP2B1	2.47e-06	168	227	8	23e0e1592d7400012d289adb10c7598285bae2e9
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH NCF2 SGK3 PIM1 TNFAIP8L2 MPEG1 ETHE1	2.94e-06	172	227	8	b26fc612f232e8e273825ac2d2e5519cbb7322cf
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TRH NCF2 SGK3 TNFAIP8L2 MPEG1 ETHE1 LRP1	2.94e-06	172	227	8	a53c906539557594ef10368bc29aec4af063fd37
ToppCell	droplet-Lung-LUNG-1m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH NCF2 SGK3 PIM1 TNFAIP8L2 MPEG1 ETHE1	2.94e-06	172	227	8	07bf95ffe77347b4f3159cb88adeaddc1b4796b7
ToppCell	droplet-Lung-nan-21m-Myeloid-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH NCF2 SGK3 PIM1 TNFAIP8L2 MPEG1 ETHE1	3.07e-06	173	227	8	9019049b1e2a24cb0bbbc620d64ef29dd18cc4c6
ToppCell	droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB TRH NCF2 SGK3 TNFAIP8L2 MPEG1 ETHE1 LRP1	3.07e-06	173	227	8	9acad7ec70f713fe3db6cef7bbe3b183bf16ae67
ToppCell	droplet-Lung-nan-21m-Myeloid-Classical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH NCF2 SGK3 PIM1 TNFAIP8L2 MPEG1 ETHE1	3.07e-06	173	227	8	077029eecfe636a5baf5f70464e1713b3f6b4274
ToppCell	PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB MGAT4B TRIM29 MKI67 DIAPH3 BCAR3 IQGAP3 MPEG1	3.20e-06	174	227	8	65147b0f8c2ccadd5685430d31081520c157536a
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PLK2 PARVB GCK DST NR0B1 PDE11A APLP1 PNMA6A	3.34e-06	175	227	8	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB TRH TRIM29 BCAR3 MPEG1 E2F1 TG CDH1	3.49e-06	176	227	8	b0b87eebcf5c994386b39ca607e17f10e9d9de74
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB SPINT1 NCF2 TRIM29 FFAR4 BCAR3 ITPRIPL2 MPEG1	3.49e-06	176	227	8	e74ad0db3b05897edcfabeb11008ede2b9eeb638
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYBB TRH TRIM29 MKI67 MPEG1 E2F1 LRP1 CDH1	3.64e-06	177	227	8	67cc3a6461db5e0678f96b18224aeb83ad34b0f4
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	SPARC TRIM29 ITGB5 PKLR IQGAP3 CAPN11 EGF CDH1	3.95e-06	179	227	8	4e0cf069bc47328eda753a4edc7e89b8915d52bb
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 IMPA2 SPINT1 COL4A5 ANK3 GRB7 TENM4 CDH1	4.29e-06	181	227	8	0513b9e6673ff7bf8e72ba123ca3794b65d10170
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TANC2 ABCA3 IMPA2 COL4A5 ARSJ ANK3 TENM4 CDH1	4.47e-06	182	227	8	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D175\|Adult / Lineage, Cell type, age group and donor	IL11RA QPCTL RYR3 SYNJ2 COL6A2 GPR20 FAT3 TENM4	4.47e-06	182	227	8	ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8
ToppCell	facs-Trachea-24m-Hematologic\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYBB SNX20 NCF2 SYK MPEG1 ACTR2 IL2RB ATP2B1	4.47e-06	182	227	8	a6162498a8a41a7fdf84d744e4203f99dfb284fa
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ABCA3 ACADL ADGRV1 SLC9C1 ALOX15B ANK3 SNX25 PARD3	4.65e-06	183	227	8	6847c1252d6bb105524f812658112517fd351eab
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	ABCA3 ACADL MYO6 ADGRV1 ANK3 SNX25 PARD3 CDH1	4.65e-06	183	227	8	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TANC2 SYT9 SYK COL4A5 ARSJ ANK3 ST6GAL1 CDH1	4.65e-06	183	227	8	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 RYR2 RYR3 FAT3 TENM4 CSMD1 OTOG	4.84e-06	184	227	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 IMPA2 ADGRV1 COL4A5 ANK3 ACAD10 GSAP CDH1	4.84e-06	184	227	8	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 RYR2 RYR3 FAT3 TENM4 CSMD1 OTOG	4.84e-06	184	227	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 ACADL ADGRV1 ALOX15B ANK3 GRB7 SNX25 CDH1	4.84e-06	184	227	8	0ba243cbf69b4fe6ae100a7f0314317bec38026c
ToppCell	COVID-19-Epithelial_cells-AT2\|COVID-19 / group, cell type (main and fine annotations)	ABCA3 MYO6 ADGRV1 ALOX15B ANK3 EGF SNX25 CDH1	4.84e-06	184	227	8	369b82f793deab672204558ae4e112cfa5aa9ccc
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 CSMD3 RYR2 RYR3 FAT3 TENM4 CSMD1 OTOG	4.84e-06	184	227	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	367C-Epithelial_cells-Epithelial-A_(AT2)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ABCA3 ACADL ADGRV1 ALOX15B ANK3 GRB7 SNX25 CDH1	4.84e-06	184	227	8	2a8338e94937686a148b5433515700ca0f674058
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 IMPA2 SPINT1 COL4A5 ARSJ ANK3 TENM4 CDH1	5.04e-06	185	227	8	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYBB TRH NCF2 TRIM29 FFAR4 BCAR3 MPEG1 ACTR2	5.04e-06	185	227	8	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPM1J KCNJ12 COL4A5 COL6A3 GPR20 LAMA5 MST1R LRP1	5.04e-06	185	227	8	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPM1J KCNJ12 COL4A5 COL6A3 GPR20 LAMA5 MST1R LRP1	5.04e-06	185	227	8	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	Myeloid-B_(Activated_Macrophage)\|World / shred on cell class and cell subclass (v4)	CYBB TRIM29 DST SYK MPEG1 GSAP ACTR2 LRP1	5.24e-06	186	227	8	33d731a7883d75e4e7db83b641cdb1e9a39938bf
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages\|GI_small-bowel / Manually curated celltypes from each tissue	CYBB HLA-DRA ITGB5 SYK MMP1 ALOX15B TNFAIP8L2 MPEG1	5.24e-06	186	227	8	a0cc925af97e47efd0c9bc17c37963e8ad4e5b35
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 IMPA2 SPINT1 COL4A5 ARSJ ANK3 GRB7 CDH1	5.45e-06	187	227	8	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DST DIAPH3 COL4A5 ARSJ GRK5 LAMA5 PAPSS2 CDH1	5.45e-06	187	227	8	d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA3 ACADL MYO6 ADGRV1 ALOX15B ANK3 GSAP SNX25	5.45e-06	187	227	8	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	moderate-Epithelial-Ionocyte\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PLK2 IMPA2 DST PDE11A ARSJ FAT3 B4GALNT2 PNMA6A	5.45e-06	187	227	8	3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	DST DIAPH3 COL4A5 ARSJ GRK5 LAMA5 PAPSS2 CDH1	5.45e-06	187	227	8	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TANC2 ABCA3 TRH NPC1 ANK3 GSAP SNX25 CDH1	5.67e-06	188	227	8	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA3 IMPA2 SPINT1 COL4A5 ANK3 GRB7 GSAP CDH1	5.67e-06	188	227	8	43a0508d2524a5b310e89e9422843dcaab999bc3
Drug	NSC49633	DST COL4A5 COL6A2 COL6A3 APLP1 GBA3 NOX1	8.52e-07	53	224	7	CID000023340
Drug	Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A	DNAJB12 MAPT INPP5B PASK DOCK6 POLE NLRX1 E2F1 SBNO2 NOX1 PARD3	4.11e-06	196	224	11	5079_DN
Drug	Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A	ACACB MAPT PATZ1 INPP5B LRIG2 SYNJ2 KDM6A COL6A2 OGFR E2F1 SBNO2	4.31e-06	197	224	11	6611_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	MAPT SYNJ2 SLC35A2 SYK CHPF2 OSGIN2 DOCK6 KDM6A OGFR E2F1 SOS1	4.75e-06	199	224	11	6977_DN
Drug	miglustat	ABCA1 SPARC PKLR NPC1 LGALS8 TG SLC5A4 GBA3	5.28e-06	97	224	8	CID000051634
Drug	AC1L9DYZ	ACADL OXCT2 KIR3DL2 ACAD10	1.51e-05	16	224	4	CID000443062
Drug	magnesium	SPHK2 NDOR1 IMPA2 TRH OXCT2 GCK ADGRV1 PSMA8 RYR2 RYR3 PASK FARSA KCNJ12 PKLR FGB MMP1 RAD51C GPLD1 COL4A5 MRM2 OGFR LAMA5 GRIN2D PAPSS2 GBA3 ACP4 SNRPA CDH1 ATP2B1 SOS1	1.79e-05	1325	224	30	CID000000888
Drug	MBED	RYR2 RYR3 B4GALNT2	1.84e-05	6	224	3	CID000129958
Drug	putrescine	MYO6 SRM PAOX NPC1 POLE GRIN2D TG EGF B4GALNT2	2.15e-05	153	224	9	CID000001045
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; PC3; HT_HG-U133A	DNAJB12 IL11RA MAPT TRIM29 PASK SYNJ2 OGFR GRB7 LGALS8 TENM4	2.26e-05	193	224	10	3799_DN
Drug	Pimozide [2062-78-4]; Up 200; 8.6uM; PC3; HT_HG-U133A	ABCA3 SPARC INPP5B NOD1 SYNJ2 PIM1 NLRX1 SBNO2 EGF PARD3	2.36e-05	194	224	10	7132_UP
Drug	Methyldopate hydrochloride [2508-79-4]; Up 200; 14.6uM; HL60; HT_HG-U133A	QPCTL TRH ACACB MYO6 PARVB SLC35A2 PKLR DOCK6 OGFR GRB7	2.47e-05	195	224	10	2940_UP
Drug	Rgd Peptide	SPARC PTCHD3 ITGB5 SLC35A2 FGB MMP1 COL4A5 COL6A2 COL6A3 LAMA5 EGF	2.65e-05	239	224	11	CID000104802
Drug	Chlorzoxazone [95-25-0]; Down 200; 23.6uM; MCF7; HT_HG-U133A	DNAJB12 PAOX PIM1 SLC35A2 OGFR NLRX1 GRB7 APLP1 SBNO2 NOX1	2.70e-05	197	224	10	2263_DN
Drug	AC1MW7VF	CYBB RYR2 RYR3 B4GALNT2	3.15e-05	19	224	4	CID000414699
Disease	Malignant neoplasm of breast	ABCA3 ACY1 TRIM29 ADAR NDUFS3 SGK3 SYNJ2 PIM1 SLC35A2 MKI67 MMP1 BCAR3 RAD51C MAGOHB GRB7 E2F1 GRIN2D TRAPPC8 EGF TLL1 CDH1 SORL1	1.58e-05	1074	217	22	C0006142
Disease	stomach carcinoma (is_marker_for)	SPINT1 MMP1 GRB7 MDC1	2.69e-05	24	217	4	DOID:5517 (is_marker_for)
Disease	lung non-small cell carcinoma (is_implicated_in)	CHRNA3 PAOX FHIT KDM6A POLE E2F1 EGF	7.93e-05	139	217	7	DOID:3908 (is_implicated_in)
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	1.61e-04	3	217	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	1.61e-04	3	217	2	DOID:8545 (implicated_via_orthology)
Disease	Prescription Drug Abuse	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C4316881
Disease	Substance-Related Disorders	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0236969
Disease	Organic Mental Disorders, Substance-Induced	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0029231
Disease	Drug habituation	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0013170
Disease	Drug abuse	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0013146
Disease	Drug Use Disorders	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0013222
Disease	Drug Dependence	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C1510472
Disease	Substance Dependence	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0038580
Disease	Substance Use Disorders	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.13e-04	115	217	6	C0038586
Disease	Substance abuse problem	MYO6 CSMD3 BCAR3 FHIT GBA3 CSMD1	2.24e-04	116	217	6	C0740858
Disease	reticulocyte count	SPHK2 PLK2 ABCA1 NDOR1 MAPT PATZ1 GCKR FFAR4 NOD1 KCNJ12 PKLR ST6GAL1 SBNO2 MRPL4 EGF ADGRD2 SLC45A1 CDH1 ATP2B1	2.83e-04	1045	217	19	EFO_0007986
Disease	Ullrich congenital muscular dystrophy 1	COL6A2 COL6A3	3.20e-04	4	217	2	C0410179
Disease	Bethlem myopathy (is_implicated_in)	COL6A2 COL6A3	3.20e-04	4	217	2	DOID:0050663 (is_implicated_in)
Disease	ANGPTL8 measurement	GCKR DOCK6	3.20e-04	4	217	2	EFO_0020861
Disease	Ullrich congenital muscular dystrophy	COL6A2 COL6A3	3.20e-04	4	217	2	cv:C4551860
Disease	Bethlem myopathy	COL6A2 COL6A3	3.20e-04	4	217	2	cv:C1834674
Disease	BETHLEM MYOPATHY 1	COL6A2 COL6A3	3.20e-04	4	217	2	C1834674
Disease	vascular dementia (implicated_via_orthology)	MAPT NOX1	3.20e-04	4	217	2	DOID:8725 (implicated_via_orthology)
Disease	Ullrich congenital muscular dystrophy (is_implicated_in)	COL6A2 COL6A3	3.20e-04	4	217	2	DOID:0050558 (is_implicated_in)
Disease	Chronic granulomatous disease	CYBB NCF2	5.31e-04	5	217	2	cv:C0018203
Disease	Mammary Carcinoma, Human	ADAR NDUFS3 SYNJ2 PIM1 MKI67 MMP1 BCAR3 RAD51C GRB7 E2F1 EGF CDH1	5.53e-04	525	217	12	C4704874
Disease	Mammary Neoplasms, Human	ADAR NDUFS3 SYNJ2 PIM1 MKI67 MMP1 BCAR3 RAD51C GRB7 E2F1 EGF CDH1	5.53e-04	525	217	12	C1257931
Disease	Mammary Neoplasms	ADAR NDUFS3 SYNJ2 PIM1 MKI67 MMP1 BCAR3 RAD51C GRB7 E2F1 EGF CDH1	5.72e-04	527	217	12	C1458155
Disease	Breast Carcinoma	ADAR NDUFS3 SYNJ2 PIM1 MKI67 MMP1 BCAR3 RAD51C GRB7 E2F1 EGF CDH1	6.85e-04	538	217	12	C0678222
Disease	reticulocyte measurement	SPHK2 ABCA1 NDOR1 MAPT PATZ1 GCKR GGT7 NOD1 KCNJ12 PKLR ST6GAL1 SBNO2 MRPL4 EGF ADGRD2 SLC45A1 CDH1 ATP2B1	8.37e-04	1053	217	18	EFO_0010700
Disease	cancer (implicated_via_orthology)	PSMC2 PARVB TRIP12 ITGB5 DST POLE RANBP6 SMARCC2	8.74e-04	268	217	8	DOID:162 (implicated_via_orthology)
Disease	coronary artery disease (is_implicated_in)	ABCA1 GCK FGB MMP1 TLL1	8.78e-04	100	217	5	DOID:3393 (is_implicated_in)
Disease	migraine disorder, pulse pressure measurement	ITGB5 LRP1 ICA1L	9.00e-04	26	217	3	EFO_0005763, MONDO_0005277
Disease	Alzheimer disease	ABCA1 TRH PARVB MTMR2 FAM47E KIR3DL2 ANK3 MROH1 CSMD1 SORL1 OR2W6P	9.95e-04	485	217	11	MONDO_0004975
Disease	lung small cell carcinoma (is_implicated_in)	CHRNA3 KDM6A E2F1	1.12e-03	28	217	3	DOID:5409 (is_implicated_in)
Disease	Ischemic stroke, factor VII measurement	GCKR FGB PARD3	1.24e-03	29	217	3	EFO_0004619, HP_0002140
Disease	hair morphology	EGF WNT10A CSMD1	1.24e-03	29	217	3	EFO_0005038
Disease	level of Triacylglycerol (49:2) in blood serum	GCKR ADGRD2	1.46e-03	8	217	2	OBA_2045162
Disease	Abnormality of refraction	MAPT GCKR ZGPAT NOD1 FHIT PDE11A GALNT14 ANK3 FAT3 FER1L4 TLL1 WNT10A PARD3	1.53e-03	673	217	13	HP_0000539
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	GGNBP2 TRIP12 ZGPAT MTMR11 KCNJ12 FHIT NPC1 MST1R LRP1	1.58e-03	364	217	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	triacylglycerol 54:5 measurement	GCKR MAGEC1 KCNJ18	1.66e-03	32	217	3	EFO_0010423
Disease	ceramide measurement	SPHK2 ABCA1 GCKR MDN1 FHIT ARSJ CHP2	1.85e-03	235	217	7	EFO_0010222
Disease	pulse pressure measurement, migraine without aura, susceptibility to, 4	ITGB5 LRP1	1.87e-03	9	217	2	EFO_0005763, MONDO_0011847
Disease	cardiomyopathy (implicated_via_orthology)	SPHK2 SPARC AMN LRP1	1.88e-03	71	217	4	DOID:0050700 (implicated_via_orthology)
Disease	retinal detachment, retinal break	MAPT TRIM29 FAT3	2.16e-03	35	217	3	EFO_0005773, EFO_0010698
Disease	cerebrospinal fluid clusterin measurement	DST TLL1 CSMD1	2.16e-03	35	217	3	EFO_0007657
Disease	free cholesterol in small HDL measurement	ABCA1 GCKR DOCK6	2.16e-03	35	217	3	EFO_0022270
Disease	lung cancer (is_implicated_in)	CHD4 CHRNA3 MMP1 POLE	2.19e-03	74	217	4	DOID:1324 (is_implicated_in)
Disease	Colorectal Carcinoma	ABCA1 ABCA3 SPARC SYT9 CSMD3 MKI67 MMP1 KDM6A POLE LRP1 B4GALNT2 CDH1 SORL1	2.21e-03	702	217	13	C0009402
Disease	arrhythmogenic right ventricular cardiomyopathy (is_implicated_in)	RYR2 TMEM43	2.33e-03	10	217	2	DOID:0050431 (is_implicated_in)
Disease	Congenital Disorders of Glycosylation	FCSK SLC35A2	2.33e-03	10	217	2	C0282577
Disease	chronic obstructive pulmonary disease, chronic bronchitis	CHRNA3 CSMD1	2.33e-03	10	217	2	EFO_0000341, EFO_0006505
Disease	endometrial cancer (is_implicated_in)	POLE EGF CDH1	2.34e-03	36	217	3	DOID:1380 (is_implicated_in)
Disease	t-tau measurement	PTCHD3 MAPT SYT9 FHIT PARD3	2.44e-03	126	217	5	EFO_0004760
Disease	Alzheimer disease, educational attainment	PLK2 MAPT MTMR2 BCAR3 NPC1 MEIOSIN SORL1	2.44e-03	247	217	7	EFO_0011015, MONDO_0004975
Disease	linoleic acid measurement	ABCA1 GCKR MKI67 FGB DOCK6 FER1L4	2.62e-03	186	217	6	EFO_0006807
Disease	venous thromboembolism, factor VII measurement	GCKR GRK5 PARD3	2.74e-03	38	217	3	EFO_0004286, EFO_0004619
Disease	free cholesterol in large HDL measurement	ABCA1 GCKR CYP2W1 DOCK6	2.78e-03	79	217	4	EFO_0022157
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	GCKR B4GALNT2	2.83e-03	11	217	2	OBA_2045170
Disease	late onset Parkinson's disease (is_implicated_in)	MAPT HLA-DRA	2.83e-03	11	217	2	DOID:0060892 (is_implicated_in)
Disease	Prostatic Intraepithelial Neoplasias	PIM1 CDH1	2.83e-03	11	217	2	C0282612
Disease	pulmonary hypertension (biomarker_via_orthology)	CYBB RYR2 RYR3 NOX1	2.91e-03	80	217	4	DOID:6432 (biomarker_via_orthology)
Disease	cholesterol in large HDL measurement	ABCA1 GCKR CYP2W1 DOCK6	2.91e-03	80	217	4	EFO_0021900
Disease	smoking cessation	DNAJB12 DEF8 CSMD3 CHRNA3 ZGPAT ANK3 MST1R ICA1L	2.93e-03	325	217	8	EFO_0004319
Disease	Alzheimer's disease (is_implicated_in)	ABCA1 MAPT NCF2 LRP1 SORL1	2.99e-03	132	217	5	DOID:10652 (is_implicated_in)
Disease	Nonsyndromic Deafness	MYO6 ADGRV1 GIPC3 OTOG	3.04e-03	81	217	4	C3711374
Disease	ovarian neoplasm	IL11RA SPARC MKI67 RAD51C CDH1	3.18e-03	134	217	5	C0919267
Disease	alcohol use disorder (implicated_via_orthology)	CHRNA3 RYR2 RYR3 KDM6A GRK5 SMARCC2	3.30e-03	195	217	6	DOID:1574 (implicated_via_orthology)
Disease	endometrial carcinoma (is_implicated_in)	SPARC POLE	3.38e-03	12	217	2	DOID:2871 (is_implicated_in)
Disease	autoimmune thyroiditis (is_implicated_in)	HLA-DRA TG	3.38e-03	12	217	2	DOID:7188 (is_implicated_in)
Disease	Mesothelioma	SYK FHIT CDH1	3.40e-03	41	217	3	C0025500
Disease	end stage renal disease (is_implicated_in)	GCKR FGB MMP1	3.40e-03	41	217	3	DOID:783 (is_implicated_in)
Disease	mean corpuscular hemoglobin concentration	NDOR1 GON4L GCKR ITGB5 ZGPAT PIM1 KCNJ12 SLC35A2 MTMR2 FAM47E NEURL1B MPST ACAD10 SYF2 EGF CDH1 IL2RB	3.48e-03	1105	217	17	EFO_0004528
Disease	Malignant neoplasm of ovary	IL11RA SPARC MKI67 RAD51C CDH1	3.50e-03	137	217	5	C1140680
Disease	Autism Spectrum Disorders	TRIP12 RYR2 IQGAP3 PAH	3.62e-03	85	217	4	C1510586
Disease	liver fat measurement	PARVB GCKR RIOX2	3.90e-03	43	217	3	EFO_0010821
Disease	triglycerides in large LDL measurement	SPHK2 ABCA1 GCKR	3.90e-03	43	217	3	EFO_0022319
Disease	Respiratory Depression	TRH MAPT	3.98e-03	13	217	2	C0235063
Disease	Respiratory Failure	TRH MAPT	3.98e-03	13	217	2	C1145670
Disease	Respiratory Insufficiency	TRH MAPT	3.98e-03	13	217	2	C0035229
Disease	cholelithiasis	GCKR ADAR SYNJ2 UGDH	4.10e-03	88	217	4	EFO_0004799
Disease	schizophrenia (is_marker_for)	ANK3 GRIN2D EGF	4.16e-03	44	217	3	DOID:5419 (is_marker_for)
Disease	high grade glioma (implicated_via_orthology)	MKI67 POLE ST6GAL1	4.16e-03	44	217	3	DOID:3070 (implicated_via_orthology)
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	PLK2 ABCA1 ACACB GCK GCKR DOCK6 TENM4	4.32e-03	274	217	7	EFO_0004530, EFO_0004612
Disease	stroke	SPARC IMPA2 TRIM29 SLC39A13 FGB	4.33e-03	144	217	5	EFO_0000712
Disease	bronchopulmonary dysplasia	CSMD3 CYP2W1 FHIT	4.43e-03	45	217	3	MONDO_0019091
Disease	HbA1c measurement	NDOR1 ACACB GCK GCKR PKLR MPST ST6GAL1 GSAP SYF2 EGF CDH1 SOS1	4.47e-03	675	217	12	EFO_0004541
Disease	Colorectal Neoplasms	ABCA1 ABCA3 SPARC MKI67 MMP1 POLE CDH1	4.58e-03	277	217	7	C0009404
Disease	membranous glomerulonephritis (biomarker_via_orthology)	ABCA1 SPARC	4.62e-03	14	217	2	DOID:10976 (biomarker_via_orthology)
Disease	triacylglycerol 46:2 measurement	GCKR CSMD1	4.62e-03	14	217	2	EFO_0010402
Disease	triacylglycerol 52:1 measurement	GCKR CSMD1	4.62e-03	14	217	2	EFO_0010413
Disease	urinary bladder cancer (biomarker_via_orthology)	MKI67 CDH1	4.62e-03	14	217	2	DOID:11054 (biomarker_via_orthology)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	FPGT ACY1 CSMD3 KDM6A GRB7	4.86e-03	148	217	5	C0279702
Disease	Anilide use measurement	MAPT LRP1	5.31e-03	15	217	2	EFO_0009938
Disease	thrombosis (is_implicated_in)	FGB MMP1	5.31e-03	15	217	2	DOID:0060903 (is_implicated_in)
Disease	level of C-X-C motif chemokine 3 in blood serum	CLK2 TNFAIP8L2	5.31e-03	15	217	2	OBA_2041208
Disease	total lipids in lipoprotein particles measurement	ABCA1 GCKR DOCK6	5.32e-03	48	217	3	EFO_0022309
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ABCA1 GCKR FCSK FGB DOCK6	5.58e-03	153	217	5	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ABCA1 GCKR FCSK FGB DOCK6	5.58e-03	153	217	5	EFO_0004611, EFO_0020944
Disease	lung adenocarcinoma (is_implicated_in)	CHD4 CHRNA3 EGF	5.63e-03	49	217	3	DOID:3910 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
IRDAPFHTGDDRFLA	nan	71	A8MZ25
FHTGDDRFLARENFP	nan	76	A8MZ25
TFFRAELVHPALERS	AKR1C8	91	Q5T2L2
SEPGSRIHLIFNDFD	CSMD1	616	Q96PZ7
EAEPGHSIKITFERF	CSMD3	926	Q7Z407
LPVARASEAEHRLFE	CHRNA3	26	P32297
DIGIRRIFSPEHDIF	ACADL	46	P28330
FLAHTERLQRVGFDP	B4GALNT2	476	Q8NHY0
VGFDPRLQRVAHSEF	B4GALNT2	486	Q8NHY0
QDRHGETFTFRDPHL	BCAR3	96	O75815
GEALQHPFFARLRAE	CLK2	471	P49760
NASGLEVPLFHLFAR	GPR20	26	Q99678
HLFARLDEELHGTFP	GPR20	36	Q99678
LTGREHVEFFALLRG	ABCA1	2001	O95477
FRGGVILVSHDERFI	ABCF3	656	Q9NUQ8
EPHGVLNFALSSRFV	ADGRV1	2821	Q8WXG9
RGFPFHSSEIQRDEL	APLP1	556	P51693
FPRELSLHFGREFVD	C14orf28	76	Q4W4Y0
LDANGHFVKREAFLP	CYP2W1	411	Q8TAV3
FILPRESTHRFEGLF	ABCA3	796	Q99758
LRFADGPDEVHRATV	ACAD10	1036	Q6JQN1
IGLEDFIFAHVRGET	GIPC3	96	Q8TF64
GLFFVDAERVPCRHD	AMN	126	Q9BXJ7
FEPHRDADFLLRVFT	CAPN11	526	Q9UMQ6
SPDDLDFRLHIRNEF	DIAPH3	351	Q9NSV4
VFPFREELLAAIANH	DHX16	401	O60231
PFSQDDFLRSLEHAG	DENND6B	456	Q8NEG7
ERVFAKPFLASLDGH	DCAF13	51	Q9NV06
EKFFDIDSGRNAPLH	ATP2B1	951	P20020
GERFEAPEALFQPHL	ACTR2	256	P61160
RLAFRFAGPHAESAE	NBPF4	611	Q96M43
VDGIAFPFRHDLDDL	RAD51C	241	O43502
FGSVEDDHIPFLRRG	QPCTL	321	Q9NXS2
DLERLDPAGAAETFH	JAK3	241	P52333
LGFTFSFPVRHEDID	GCK	146	P35557
EHFFLHREGISEDPS	KIR3DL2	151	P43630
VAIDRSGLPLHFFIN	MPEG1	301	Q2M385
AFLRELETVAAHQFP	NCLN	336	Q969V3
EAVATFLIRHRFAEP	PPME1	361	Q9Y570
LDLHRDFTVASPAEF	ACACB	236	O00763
PEEDFFSIHIRAAGD	NOX1	346	Q9Y5S8
AARDFLFPHLREEIL	RAB3GAP2	16	Q9H2M9
DFEIGHFFRERIVPR	NAP1L4	316	Q99733
NARKIHESAGLPFFE	PAPSS2	131	O95340
DPARHNEFDFISGTR	PAPSS2	566	O95340
GLPHAVRVSARDFLD	IL11RA	286	Q14626
SGLDLFAFIDRHPRL	PASK	1086	Q96RG2
FRNRFVELHFDELPS	MDN1	1211	Q9NU22
SHLEDFFARTLVPRV	MAD2L1BP	136	Q15013
FEGREDSVFAHPRKL	MAGEA2	231	P43356
VHLERAQPFGFIDSD	MDC1	316	Q14676
GREHFAFGEPRELLT	MAGEC1	1031	O60732
RDGLSPQARHDFDRL	KCNJ12	401	Q14500
IFRALEGEAHRVLFG	NCF2	236	P19878
FAPDAELHIFRVFTN	MBTPS1	266	Q14703
LERFFFRSGNIEHPE	MGAT4B	446	Q9UQ53
DFIAHLLGRAEPEFA	GGNBP2	266	Q9H3C7
RGHVPSDADRFQVDL	LGALS8	36	O00214
EFFLLALHDSVRVPD	MTMR11	456	A4FU01
NHLPFFFGNITREEA	SYK	11	P43405
RFHGVLPDDEDALRT	DST	6946	Q03001
QEDAHTQFPERGRFL	HMCN2	3636	Q8NDA2
FIDPAAFLGLTHLEE	LRRC17	306	Q8N6Y2
KRGLSHPFSIDVFED	LRP1	4086	Q07954
PHLIFILADDQGFRD	ARSJ	76	Q5FYB0
VQIHFAAGDFFRDPL	ASMTL	501	O95671
FSLRGEDVDLHLFLP	KIAA1109	581	Q2LD37
LRFTFRGHEDPPEEE	FER1L4	1031	A9Z1Z3
GLDSRLFGFVRFHED	KDM6A	51	O15550
FETERKHFTILDAPG	GSPT2	276	Q8IYD1
NEEGFFSARGHRPLD	FGB	36	P02675
PFFSDVKGDHRLVLA	FFAR4	26	Q5NUL3
HALFKGDFRITSPRD	PCNX3	1611	Q9H6A9
HLIDFRESAPGALRE	GGT7	201	Q9UJ14
AAHGVAEPELRAFLR	KCNK12	81	Q9HB15
GFSDRPHLERILFVV	OR2W3	16	Q7Z3T1
VGFSDRPHLELIVFV	OR2W6P	21	Q8NHA6
AIHVLGPIDFEESRF	PCDHGC5	301	Q9Y5F6
LDFGEVETFLDRHPE	PDE11A	6	Q9HCR9
EEVFAFLLRFPHVAL	NOD1	266	Q9Y239
HADADRSPVFLQFID	MTMR2	471	Q13614
DLRFGVEHGVDIVFA	PKLR	271	P30613
GPRAFLSREEAQHFI	TEPSIN	256	Q96N21
EGPARAFHELSREEQ	POLE	701	Q07864
VSFGGHLRPELFDEN	MKI67	506	P46013
RFFLHGVTLVPIEEF	LAMA5	1181	O15230
EERQFGPTFALDTVH	NLRX1	96	Q86UT6
HFDSFGLRLPRDITE	POGK	146	Q9P215
GFLLREHFTPEATQL	PARP4	226	Q9UKK3
GLLHVAIRIRPFFDS	MROH1	1446	Q8NDA8
ERFPSHRFIAEEAAA	IMPA2	71	O14732
GFRHLLPLTDRVDSF	ITGB5	216	P18084
FPALLAQEDVARIHF	MEIOSIN	281	C9JSJ3
LGANSAPLFHDELFR	GPR4	146	P46093
DFSGHAGRVIENPRE	GRB7	376	Q14451
IEDLPASHFRNVIFD	IQGAP3	1551	Q86VI3
ELLGHVPLFSDRSFA	PAH	286	P00439
GPSHFQDVRLIEFDI	NDOR1	221	Q9UHB4
SDHPELLRFREDSFQ	NPHP4	1366	O75161
RFERDAFDTLFDHAP	PARVB	236	Q9HBI1
DFRDVRGFLIGDHSD	GCKR	356	Q14397
FALERPFGNVESRLD	GALNT14	376	Q96FL9
GPHDRFIELNSTLFL	NR0B1	421	P51843
DQHFGPFFRTEQLII	NPC1	396	O15118
RVGDESFPAHRAVLA	PATZ1	46	Q9HBE1
PLVFVALVFRHGDRA	ACP4	31	Q9BZG2
AVLFDTLLHPDADFG	OSGIN2	86	Q9Y236
GARPVQLSLFFDILH	FCSK	256	Q8N0W3
NSGHLPRDRIAEDFV	GSAP	196	A4D1B5
RFHDLRPDEVADLFQ	FHIT	46	P49789
LFLHESPGEDRLFRV	FAM124B	71	Q9H5Z6
HLDSGDLARFPEVVF	HENMT1	136	Q5T8I9
HVREDFSGLLPEEFI	E2F1	386	Q01094
VHVLEEGAFPFRLKD	DOCK6	731	Q96HP0
IARDTLPRLHDFAEG	DOCK6	1171	Q96HP0
RDGSAFEDGLRHPFI	ADAR	1086	P55265
SRFGLFHVDFEDPAR	GBA3	431	Q9H227
PFLIFSHGNSIFRID	EGF	46	P01133
HPFKGFLLEARNAED	FRRS1	71	Q6ZNA5
SGPLFNFDVHDDVRL	FAM50A	276	Q14320
HRGFEADISPEDLFN	DNAJB12	191	Q9NXW2
LEEFRSAPFIECHGR	COL4A5	1621	P29400
GVRPDGFAHIRDFVS	COL6A3	1446	P12111
FAVVITDGRHDPRDD	COL6A2	726	P12110
IRFENVSPEDFVGLH	FAT3	3651	Q8TDW7
FERHLEFEARTLSPG	IL2RB	161	P14784
LQDEFSIFFDHLRPA	GON4L	1766	Q3T8J9
QFFTLEGRHPDRSVF	ANK3	3501	Q12955
GVSETVFLPREDHLF	HLA-DRA	156	P01903
NSFRRELDALGHELP	BID	31	P55957
DLHIEDGDSIRFGRF	ETHE1	111	O95571
PEEDFFSIHIRIVGD	CYBB	346	P04839
LSEDHFSRPVGLFLA	DEF8	126	Q6ZN54
PSDQAEVDHLLRIFF	ENO4	151	A6NNW6
FQQPGLRSEFEHIRD	INPP5B	851	P32019
EEGAAEVKRHPFFRN	GRK5	436	P34947
RFLPSQLFDLGFHVA	ICA1L	396	Q8NDH6
PERFHNLEGFLEEFA	CHD4	921	Q14839
HEVGDFAILLRAGFD	SLC39A13	261	Q96H72
LVDFGDLHPQRSFRE	SLC45A1	106	Q9Y2W3
RFHEPAKDIGFNVAV	RYR2	4086	Q92736
GELFFHLQRERSFPE	SGK3	246	Q96BR1
EAFDFIARDPAETLH	NIT1	86	Q86X76
EHLRDFIHVDFDPPG	CFAP74	556	Q9C0B2
DFDLSQLHRGLDARP	CDH1	766	P12830
AFLGALLDHFEITPE	COL6A6	1986	A6NMZ7
HGVFVLDPFDDLKHR	FPGT	216	O14772
EHGTDIHPISLFFRD	PTCHD3	576	Q3KNS1
SLLVFRQEDAFHPRE	PARD3	541	Q8TEW0
EFILAGLTDHPEFRQ	OR8B2	11	Q96RD0
LEAADRPNFFLHVTA	OTOG	1311	Q6ZRI0
TVPLGFLREHLDTFF	PAOX	286	Q6QHF9
APVDLLAAFDGHARE	ITPRIPL2	476	Q3MIP1
EHFQAPLVRFFLEET	OGFR	226	Q9NZT2
DFILLGFSDHPRLEA	OR2G3	11	Q8NGZ4
GFSDHPRLEAVLFVF	OR2G3	16	Q8NGZ4
IFNFRRTPAAEHAFE	ALOX15B	216	O15296
PFEHDEEIIRGQVFF	PIM1	241	P11309
HEFLEFEFRPDGKLR	MAGOHB	21	Q96A72
IEFSLPDLEGRTHIF	PSMC2	341	P35998
QVVVDHFLDLADFPR	SYT9	321	Q86SS6
HSRQLVFPRKGLDDF	FAM47E	41	Q6ZV65
RDGLSPQARHDFDRL	KCNJ18	401	B7U540
FANEPFADFHRVEGL	SORL1	406	Q92673
AAFRDHQLLEPIRDF	TRIM29	206	Q14134
LEDPHVDIIRRGDFF	TMEM43	211	Q9BTV4
RREFEERHIPGAAFF	MPST	46	P25325
RLREKHGEEFFPTSN	SYF2	151	O95926
IRHLEFLPDSFDAGS	TBC1D31	261	Q96DN5
RVGLADLHPDVFATA	MRPL4	76	Q9BYD3
SSIGAFLNRHLEDFP	SLC9C1	26	Q4G0N8
RDQHDTFFLRDPAEA	FARSA	271	Q9Y285
ATPGHRIKLAFSEFE	TLL1	806	O43897
LRLHRGLEANAPAFD	SYNJ2	271	O15056
RLAFRFAGPHAESAE	NBPF6	611	Q5VWK0
ISFVRGDHRDNSPFD	MMP1	161	P03956
LERLPRDFFSHQEEE	SNX25	646	Q9H3E2
VPAFRDEHLQGLTRF	FBXL12	161	Q9NXK8
VFFANHPDLRRILTD	NDUFS3	176	O75489
LLGSEFTHLEFPRRV	PPM1J	316	Q5JR12
EIDDHDAVLRFNGAP	ST6GAL1	201	P15907
DSFHIFRDAVTGDIP	SLC5A4	261	Q9NY91
PFHRIFLDRLEENEA	TANC2	591	Q9HCD6
EGTPFRNFEEFLHAI	SBNO2	441	Q9Y2G9
EFESFPVFQDIRLHI	SCP2D1	41	Q9UJQ7
RFDHLEVRDGPFGFS	NETO2	101	Q8NC67
AFELDPGFIHEARLR	IL9R	211	Q01113
EEFQLGLFSHEPALL	NINL	256	Q9Y2I6
DILRPGFHDRFLSQL	SOS1	301	Q07889
FPGIFGTQERHDLDI	RANBP6	166	O60518
NSVHAIERRALPEFF	SMARCC2	436	Q8TAQ2
PREVREFNGDHFLLE	OXCT2	186	Q9BYC2
EFLGLGRVFHFPEQE	PNMA6A	101	P0CW24
ASIRLFGFHVDPLFA	SLC35A2	311	P78381
VRGQHAPFLAAFRAD	ADGRD2	191	Q7Z7M1
ELFVQRPEFHALRAG	ACY1	156	Q03154
RPEFHALRAGFALDE	ACY1	161	Q03154
QRVDFPGFVRVLAHF	CHP2	76	O43745
FLEAFAANVLEPREH	CHPF2	506	Q9P2E5
RDPGFDLRLEHTHFF	C11orf54	256	Q9H0W9
EDVEFPRKHLTGNFA	SNX20	136	Q7Z614
VRFPREHQFFEDGDV	ZNF511	41	Q8NB15
AFIFDGRRVLDGLHN	UGDH	436	O60701
LFEHDRGRFFTILGL	TMEM223	36	A0PJW6
GRIRHVFDHFSDPGL	TNFAIP8L2	141	Q6P589
ADLVAAPHARFDDGL	SPHK2	551	Q9NRA0
DRFHEPAKDIGFNVA	RYR3	3981	Q15413
EDFARRGEEHLPTFR	SESN3	336	P58005
FDELQRIHFPSDKGH	SPINT1	376	O43278
LEAGDHPVELLARDF	SPARC	206	P09486
LEADLRFHATRGPDV	NEURL1B	276	A8MQ27
EAHRILEGFQPSGRF	GPLD1	436	P80108
PSHTQFDFVELLDGR	TENM4	486	Q6N022
RAKGQDAPLEFTFHV	MAPT	291	P10636
SDVHRAAFVLPEFAR	SRM	281	P19623
DADALVPLFAFHERL	TRIM72	431	Q6ZMU5
ETEFHGLRFPLSHLD	RIOX2	411	Q8IUF8
APNATGFRDLDHDRL	MRM2	156	Q9UI43
AAEHPGLDDFLRQVE	TRH	36	P20396
EEIVLGQRLHLSFPF	XKR3	21	Q5GH77
FIQEFTFRGLLPHIE	TRAPPC8	351	Q9Y2L5
DEVRAGAFEHLPSLR	TPBG	131	Q13641
DRPSLDDIIRHDFFL	PLK2	321	Q9NYY3
DDIIRHDFFLQGFTP	PLK2	326	Q9NYY3
LGSEDAAFVPFHLRR	TMEM129	41	A0AVI4
GERFSKDFLDSREPH	WNT10A	221	Q9GZT5
DRAITVFSPDGHLFQ	PSMA8	6	Q8TAA3
FRDGFESVFPLSHLQ	TRIP12	1841	Q14669
RNDPDLHFDAERLGQ	VWA7	121	Q9Y334
TFPAETIRFLQGDHF	TG	1416	P01266
IDPFDLTHFLAQGRR	MST1R	1291	Q04912
PGRHDIAFVEFDNEV	SNRPA	241	P09012
FSHGQVVSLDELRPF	ZGPAT	196	Q8N5A5
LHAFLLASRIGENPF	TYRO3	611	Q06418
EPQRHAGRIAFTDAD	TERF2IP	126	Q9NYB0
KDDGPLLVTERHFFA	LRIG2	731	O94898
IRDDEGFIIRHFAGA	MYO6	571	Q9UM54
RVHGVVFEDDSRAPA	GRIN2D	111	O15399